Neumora Therapeutics, INC. (NMRA) — DEF 14A Filings
All DEF 14A filings from Neumora Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Neumora Therapeutics Files 2025 Proxy Statement
— Apr 29, 2025 Risk: low
Neumora Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for the fiscal year ending December 31, 2024. The company, formerly -
Neumora Therapeutics Announces 2024 Annual Meeting of Stockholders
— Apr 25, 2024 Risk: low
Neumora Therapeutics, Inc. (NMRA) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. Annual Meeting scheduled for June 13, 2024, at 8:30 AM ET, h
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX